{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:25:42Z","timestamp":1792603542269,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.clim.2019.108247","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:12:03Z","timestamp":1565302323000},"page":"108247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Hypertension: An immune related disorder?"],"prefix":"10.1016","volume":"212","author":[{"given":"Eleni","family":"Sereti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon S.","family":"Stamatelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos A.","family":"Zakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Evangelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eleftheria","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2019.108247_bb0005","first-page":"e426","volume":"138","author":"Whelton","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clim.2019.108247_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.ackd.2019.03.001","article-title":"Inflammation, immunity, and oxidative stress in hypertension-Partners in Crime?","volume":"26","author":"Barrows","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.clim.2019.108247_bb0015","doi-asserted-by":"crossref","first-page":"F38","DOI":"10.1152\/ajprenal.2001.281.1.F38","article-title":"Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition","volume":"281","author":"Quiroz","year":"2001","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2019.108247_bb0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","article-title":"Immune mechanisms of hypertension","volume":"19","author":"Drummond","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2019.108247_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.phrs.2017.03.015","article-title":"Novel adaptive and innate immunity targets in hypertension","volume":"120","author":"Abais-Battad","year":"2017","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.clim.2019.108247_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-3-1","article-title":"Activation of the Fas\/Fas ligand pathway in hypertensive renal disease in Dahl\/Rapp rats","volume":"3","author":"Sanders","year":"2002","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.clim.2019.108247_bb0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15252\/msb.20145399","article-title":"Integrative network analysis reveals molecular mechanisms of blood pressure regulation","volume":"11","author":"Huan","year":"2015","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.clim.2019.108247_bb0040","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00380-018-1198-1","article-title":"Subclinical atherosclerosis and vascular stiffness in premenopausal women: association with NOS3 and CYBA polymorphisms","volume":"33","author":"Lambrinoudaki","year":"2018","journal-title":"Heart Vessel."},{"key":"10.1016\/j.clim.2019.108247_bb0045","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/art.1780190309","article-title":"Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis","volume":"19","author":"Kurata","year":"1976","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.108247_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10641963.2016.1267189","article-title":"T-cell subsets are associated with serum homocysteine concentration in patients with essential hypertension","volume":"39","author":"Xu","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.clim.2019.108247_bb0055","first-page":"257","article-title":"Passive transfer of autoimmune induced hypertension in the rat by lymph node cells","volume":"25","author":"Okuda","year":"1967","journal-title":"Tex. Rep. Biol. Med."},{"key":"10.1016\/j.clim.2019.108247_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1699-0463.1972.tb02172.x","article-title":"Inflammatory cellular reaction in hypertensive vascular disease in man","volume":"80","author":"Olsen","year":"1972","journal-title":"Acta pathologica et microbiologica Scandinavica. Section A, Pathology"},{"key":"10.1016\/j.clim.2019.108247_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2019.108247_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.HYP.0000075082.06183.4E","article-title":"Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury","volume":"42","author":"Shao","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.clim.2019.108247_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.113.00689","article-title":"Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension","volume":"62","author":"Youn","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.clim.2019.108247_bb0080","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.4049\/jimmunol.1301522","article-title":"The requirement of CD8+ T cells to initiate and augment acute cardiac inflammatory response to high blood pressure","volume":"192","author":"Ma","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2019.108247_bb0085","doi-asserted-by":"crossref","first-page":"F734","DOI":"10.1152\/ajprenal.00454.2010","article-title":"Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease","volume":"300","author":"De Miguel","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2019.108247_bb0090","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCRESAHA.116.310480","article-title":"T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-gamma","volume":"120","author":"Sun","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.clim.2019.108247_bb0095","article-title":"CD8(+) T cells stimulate Na-Cl co-transporter NCC in distal convoluted tubules leading to salt-sensitive hypertension","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2019.108247_bb0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/cvr\/cvs422","article-title":"Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension","volume":"97","author":"Nguyen","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.clim.2019.108247_bb0105","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1097\/HJH.0000000000001811","article-title":"Loss of CD31 receptor in CD4+ and CD8+ T-cell subsets in children with primary hypertension is associated with hypertension severity and hypertensive target organ damage","volume":"36","author":"Gackowska","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clim.2019.108247_bb0110","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/bmj.2.5702.146","article-title":"Raised serum IgG levels in hypertension","volume":"2","author":"Ebringer","year":"1970","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clim.2019.108247_bb0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-2478(84)90067-1","article-title":"Increased serum IgG levels in essential hypertension","volume":"8","author":"Suryaprabha","year":"1984","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2019.108247_bb0120","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004872-198902000-00003","article-title":"Increased secretion of immunoglobulins in malignant hypertension","volume":"7","author":"Hilme","year":"1989","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clim.2019.108247_bb0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00004872-200018070-00017","article-title":"Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension","volume":"18","author":"Fu","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.clim.2019.108247_bb0130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1291\/hypres.25.641","article-title":"Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension","volume":"25","author":"Liao","year":"2002","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.clim.2019.108247_bb0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2174\/1389201019666180925121254","article-title":"The role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathophysiology of preeclampsia","volume":"19","author":"Campbell","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.clim.2019.108247_bb0140","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00467-007-0452-z","article-title":"The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection","volume":"22","author":"Dragun","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.clim.2019.108247_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008351","article-title":"Angiotensin II type 1 receptor autoantibodies in postural tachycardia syndrome","volume":"7","author":"Yu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.clim.2019.108247_bb0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/HYPERTENSIONAHA.118.11828","article-title":"B-cell deficiency lowers blood pressure in mice","volume":"73","author":"Dingwell","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.clim.2019.108247_bb0155","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.115.05779","article-title":"Obligatory role for B cells in the development of angiotensin II-dependent hypertension","volume":"66","author":"Chan","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.clim.2019.108247_bb0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.immuni.2015.06.016","article-title":"Long-lived plasma cells are contained within the CD19(\u2212)CD38(hi)CD138(+) subset in human bone marrow","volume":"43","author":"Halliley","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2019.108247_bb0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/10641963.2016.1210622","article-title":"Elevated serum complement C3 levels are associated with prehypertension in an adult population","volume":"39","author":"Bao","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.clim.2019.108247_bb0170","doi-asserted-by":"crossref","first-page":"F957","DOI":"10.1152\/ajprenal.00344.2013","article-title":"Complement 3 activates the renal renin-angiotensin system by induction of epithelial-to-mesenchymal transition of the nephrotubulus in mice","volume":"305","author":"Zhou","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.clim.2019.108247_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012327","article-title":"Increased complement 3 with suppression of miR-145 induces the synthetic phenotype in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"8","author":"Chen","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.clim.2019.108247_bb0180","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1253\/circj.CJ-19-0114","article-title":"Immune disorder in atherosclerotic cardiovascular disease- clinical implications of using circulating T-cell subsets as biomarkers","volume":"83","author":"Neupane","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.clim.2019.108247_bb0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/HYPERTENSIONAHA.110.162941","article-title":"T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury","volume":"57","author":"Barhoumi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.clim.2019.108247_bb0190","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619303547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661619303547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:00:30Z","timestamp":1761494430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661619303547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":38,"alternative-id":["S1521661619303547"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.108247","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension: An immune related disorder?","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.108247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108247"}}